Business

DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026

DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026

Docmorris LtdNovember 13, 20255
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026

About this update from Docmorris Ltd

DocMorris AG/ Key word(s): Bond DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026 13.11.2025 / 17:41 CET/CESTFrauenfeld, 13 November 2025Press releaseDocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026Following the closing of the tender offer period on 12 November 2025 at 4:00pm CET, DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026 ("Bonds"). The number of tendered Bonds under the Tender Offer is 72,713 corresponding to an aggregate principal amount of CHF 72,713,000.The Company accepts the full tendered amount for a purchase price of CHF 1,035 per Bond, corresponding to 103.5% of the par value, plus accrued and unpaid interest. The expected settlement date for the Tender Offer is 17 November 2025.Following settlement of the Tender Offer, 22,259 Bonds, corresponding to an aggregate principal amount of CHF 22,259,000 will remain outstanding.Investors and analyst contact Dr. Daniel Grigat, Head of Investor Relations & Sustainability Email: [email protected], phone: +41 52 560 58 10Media contact Torben Bonnke, Director Communications Email: [email protected], phone: +49 171 864 888 1Agenda20 January 2026Full-year 2025 revenue19 March 2026Full-year 2025 results and outlook 2026 (conference call/webcast)16 April 2026Q1/2026 Trading update12 May 2026Annual General Meeting, ZurichDocMorris The Swiss-based DocMorris AG is a leading company in the fields of online pharmacy, telemedicine and marketplace with strong brands in Germany and other European countries. Deliveries are mainly from the highly automated logistics centre in Heerlen, the Netherlands. TeleClinic is Germany’s largest telemedicine platform, connecting patients with more than 5,000 physicians. DocMorris operates leading marketplaces for health and personal care products in Southern Europe. With its broad range of products and services, DocMorris is pursuing its vision of becoming the leading digital health companion for everyone to manage their health in one click. Around 1,600 employees in Germany, the Netherlands, Spain, France, Portugal and Switzerland generated an external revenue of CHF 1,085 million serving more than10 million active customers in 2024. The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN ...

View stock analysis, news, and events for Docmorris Ltd